期刊
ACTA PHARMACEUTICA SINICA B
卷 11, 期 8, 页码 2488-2504出版社
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.03.015
关键词
Three-dimensional printing technology; Drug delivery system; Pharmaceutical; Personalized medicine; Additive manufacturing; On-demand manufacturing; Advantages; Limitations and challenges
资金
- National Science and Technology Major Project (China) [2017ZX09201-003-011]
- China Pharmaceutical Association-Yiling Biomedical Innovation Project (China)
- Jingxin Pharmaceutical Co., Ltd. (Zhejiang, China)
Three-dimensional printing technology prints products layer by layer, offering competitive advantages in product design complexity, personalization, and on-demand manufacturing. This technology shows innovative potential in drug delivery systems, while also facing limitations and challenges in pharmaceutical formulation development.
Three-dimensional printing is a technology that prints the products layer-by-layer, in which materials are deposited according to the digital model designed by computer aided design (CAD) software. This technology has competitive advantages regarding product design complexity, product personalization, and on-demand manufacturing. The emergence of 3D technology provides innovative strategies and new ways to develop novel drug delivery systems. This review summarizes the application of 3D printing technologies in the pharmaceutical field, with an emphasis on the advantages of 3D printing technologies for achieving rapid drug delivery, personalized drug delivery, compound drug delivery and customized drug delivery. In addition, this article illustrates the limitations and challenges of 3D printing technologies in the field of pharmaceutical formulation development. (C) 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据